Lexaria Bioscience Corp (LEXX)

[AgentSmith]

This is a phenomenal move - regardless of whether management offered or the stakeholders came asking.

The very first thing that's going to happen when (hopefully) they identify a viable drug: It's going to be in short supply!

Technology that improves the bioavailability of the drug - so less of the active material(s) is needed per effective dose - is going to be downright priceless. (Though, practically speaking, there'll be price on it alright - wink, wink.)

Moreover, anything COVID-19 is going to be fast-tracked - anything; whether by industry or government. (Read: Any research/trials Lexaria was going to have conduct on DehydraTECH regardless to court Big Pharma for a better aspirin, or Viagra, or whatever just got a massive steroid shot.)

Finally, if Lexaria is able to demonstrate that DehydraTECH is effective for drug delivery under these circumstances, they will have done so in the single most public forum in existence in our day and age - it'll be like the Chilean miners [finally] emerging out of the rubble wearing "Oakley" sunglasses.

Side note: This is when it pays-off to be a company that values research and patents, as opposed to share price.